Helicobacter pylori infection and the CD14 C(-260)T gene polymorphism in ischemic stroke

Moon Ho Park, Joo Young Min, Seong Beom Koh, Byung Jo Kim, Min Kyu Park, Kun Woo Park, Dae Hie Lee

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Introduction: There is increasing evidence that infective pathogens such as Helicobacter pylori is linked to atherosclerosis of cerebral vessels. As an independent contributing factor, the CD14 receptor-lipopolysaccharide complex plays an important role in activating inflammatory reactions. In particular, the C(-260)T polymorphism in the CD14 receptor may be implicated in atherosclerotic disease. In this study, we investigated a possible association between H. pylori infection and the polymorphism of CD14, and ischemic stroke. Materials and methods: A total of 125 patients with ischemic stroke and 125 age- and sex-matched controls were included in the study. The stroke subtype of each of the patients was characterized based on the underlying etiology. H. pylori serologic status and the CD14 genotype were determined in both patients and controls. Results: H. pylori seropositivity was more common in the stroke patients than in the controls (80.0% vs. 60.0%, P = 0.001). Moreover, H. pylori seropositivity was more common in the stroke subtype of large artery disease (87.7%, P < 0.001). The distribution of CD14 genotypes was as follows: patients, T/T 21.6%, C/T 63.2%, C/C 15.2%; controls, T/T 19.2%, C/T 57.6%, C/C 23.2%. There was no significant difference between these two CD14 genotype distributions. Conclusions: These results suggest that H. pylori infection is a risk factor for ischemic stroke and that CD14 polymorphism is not.

Original languageEnglish
Pages (from-to)671-677
Number of pages7
JournalThrombosis Research
Volume118
Issue number6
DOIs
Publication statusPublished - 2006 Nov 6

Fingerprint

Helicobacter Infections
Helicobacter pylori
Stroke
Genes
Genotype
CD14 Antigens
Intracranial Arteriosclerosis
Arteries

Keywords

  • CD14
  • Helicobacter pylori
  • Polymorphism
  • Stroke

ASJC Scopus subject areas

  • Hematology

Cite this

Helicobacter pylori infection and the CD14 C(-260)T gene polymorphism in ischemic stroke. / Park, Moon Ho; Min, Joo Young; Koh, Seong Beom; Kim, Byung Jo; Park, Min Kyu; Park, Kun Woo; Lee, Dae Hie.

In: Thrombosis Research, Vol. 118, No. 6, 06.11.2006, p. 671-677.

Research output: Contribution to journalArticle

@article{8c17cec36f5b4ae6999d7839ec9b2b0d,
title = "Helicobacter pylori infection and the CD14 C(-260)T gene polymorphism in ischemic stroke",
abstract = "Introduction: There is increasing evidence that infective pathogens such as Helicobacter pylori is linked to atherosclerosis of cerebral vessels. As an independent contributing factor, the CD14 receptor-lipopolysaccharide complex plays an important role in activating inflammatory reactions. In particular, the C(-260)T polymorphism in the CD14 receptor may be implicated in atherosclerotic disease. In this study, we investigated a possible association between H. pylori infection and the polymorphism of CD14, and ischemic stroke. Materials and methods: A total of 125 patients with ischemic stroke and 125 age- and sex-matched controls were included in the study. The stroke subtype of each of the patients was characterized based on the underlying etiology. H. pylori serologic status and the CD14 genotype were determined in both patients and controls. Results: H. pylori seropositivity was more common in the stroke patients than in the controls (80.0{\%} vs. 60.0{\%}, P = 0.001). Moreover, H. pylori seropositivity was more common in the stroke subtype of large artery disease (87.7{\%}, P < 0.001). The distribution of CD14 genotypes was as follows: patients, T/T 21.6{\%}, C/T 63.2{\%}, C/C 15.2{\%}; controls, T/T 19.2{\%}, C/T 57.6{\%}, C/C 23.2{\%}. There was no significant difference between these two CD14 genotype distributions. Conclusions: These results suggest that H. pylori infection is a risk factor for ischemic stroke and that CD14 polymorphism is not.",
keywords = "CD14, Helicobacter pylori, Polymorphism, Stroke",
author = "Park, {Moon Ho} and Min, {Joo Young} and Koh, {Seong Beom} and Kim, {Byung Jo} and Park, {Min Kyu} and Park, {Kun Woo} and Lee, {Dae Hie}",
year = "2006",
month = "11",
day = "6",
doi = "10.1016/j.thromres.2005.11.007",
language = "English",
volume = "118",
pages = "671--677",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Helicobacter pylori infection and the CD14 C(-260)T gene polymorphism in ischemic stroke

AU - Park, Moon Ho

AU - Min, Joo Young

AU - Koh, Seong Beom

AU - Kim, Byung Jo

AU - Park, Min Kyu

AU - Park, Kun Woo

AU - Lee, Dae Hie

PY - 2006/11/6

Y1 - 2006/11/6

N2 - Introduction: There is increasing evidence that infective pathogens such as Helicobacter pylori is linked to atherosclerosis of cerebral vessels. As an independent contributing factor, the CD14 receptor-lipopolysaccharide complex plays an important role in activating inflammatory reactions. In particular, the C(-260)T polymorphism in the CD14 receptor may be implicated in atherosclerotic disease. In this study, we investigated a possible association between H. pylori infection and the polymorphism of CD14, and ischemic stroke. Materials and methods: A total of 125 patients with ischemic stroke and 125 age- and sex-matched controls were included in the study. The stroke subtype of each of the patients was characterized based on the underlying etiology. H. pylori serologic status and the CD14 genotype were determined in both patients and controls. Results: H. pylori seropositivity was more common in the stroke patients than in the controls (80.0% vs. 60.0%, P = 0.001). Moreover, H. pylori seropositivity was more common in the stroke subtype of large artery disease (87.7%, P < 0.001). The distribution of CD14 genotypes was as follows: patients, T/T 21.6%, C/T 63.2%, C/C 15.2%; controls, T/T 19.2%, C/T 57.6%, C/C 23.2%. There was no significant difference between these two CD14 genotype distributions. Conclusions: These results suggest that H. pylori infection is a risk factor for ischemic stroke and that CD14 polymorphism is not.

AB - Introduction: There is increasing evidence that infective pathogens such as Helicobacter pylori is linked to atherosclerosis of cerebral vessels. As an independent contributing factor, the CD14 receptor-lipopolysaccharide complex plays an important role in activating inflammatory reactions. In particular, the C(-260)T polymorphism in the CD14 receptor may be implicated in atherosclerotic disease. In this study, we investigated a possible association between H. pylori infection and the polymorphism of CD14, and ischemic stroke. Materials and methods: A total of 125 patients with ischemic stroke and 125 age- and sex-matched controls were included in the study. The stroke subtype of each of the patients was characterized based on the underlying etiology. H. pylori serologic status and the CD14 genotype were determined in both patients and controls. Results: H. pylori seropositivity was more common in the stroke patients than in the controls (80.0% vs. 60.0%, P = 0.001). Moreover, H. pylori seropositivity was more common in the stroke subtype of large artery disease (87.7%, P < 0.001). The distribution of CD14 genotypes was as follows: patients, T/T 21.6%, C/T 63.2%, C/C 15.2%; controls, T/T 19.2%, C/T 57.6%, C/C 23.2%. There was no significant difference between these two CD14 genotype distributions. Conclusions: These results suggest that H. pylori infection is a risk factor for ischemic stroke and that CD14 polymorphism is not.

KW - CD14

KW - Helicobacter pylori

KW - Polymorphism

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=33750473045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750473045&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2005.11.007

DO - 10.1016/j.thromres.2005.11.007

M3 - Article

C2 - 16386288

AN - SCOPUS:33750473045

VL - 118

SP - 671

EP - 677

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 6

ER -